New FDA label ruling preempts state claims...

New prescription drug labeling rule from the Food and Drug Administration says that if a label meets the agency's requirements, state law failure-to-warn suits over the drug's risks are pre-empted, but plaintiffs' lawyers have vowed to fight.

The rule is intended to make package inserts in prescription drugs easier to read and understand. The rule creates new highlights and table of contents sections to make clearer the major benefits and risks of a drug. The label must also include the date the product was approved by the FDA, in addition to contact information to encourage the reporting of adverse events and side effects. This ruling seen by some as the Bush administration helping Merck with Vioxx litigation.

Source: my.accenture.com
Need help with your packaging project?
We’ve done the legwork to identify and vet experienced packaging and processing consultants you can contact directly for your next project. Decades of combined experience in packaging line engineering, machinery selection, package and materials development, and food processing operations.
See your advisor options now.
Need help with your packaging project?